Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
20/11/2025
In October, Russia's producer price index rose by 0.7% year-on-year.
Latest
2 m ago
Bank of Canada Deputy Governor Vincent: Companies believe that the regulatory environment is not conducive to investment, and this view of companies is not insignificant.
2 m ago
The New Zealand dollar fell to its lowest point since April, wiping out gains for the year so far.
3 m ago
Novartis AG: This expansion is part of the $23 billion investment in US infrastructure over the next five years.
3 m ago
Vincent, Deputy Governor of the Bank of Canada: The impact on the Canadian economy has become too frequent and our resilience to these shocks is too fragile. Canada needs a better investment environment, more competition, and more investment in talent. We are caught in a vicious cycle; it is much more difficult to address challenges when productivity is low. Low productivity is a systemic problem that requires coordinated responses across the entire economy.
3 m ago
Novartis Pharmaceuticals: The expansion in North Carolina aims to increase production capacity and allow the company to achieve end-to-end production of 100% of its critical drugs in the United States.
See all latest